pharmaceutical

Enjoy these stories?

Are the Olympic Games still relevant?

As the world descends on Paris for the biggest show in sport, the question must be asked if the Olympic Games still hold the same

How schools are failing neurodivergent students

Neurodivergent children — those with autism, ADHD, dyslexia or other difference in brain functioning — face myriad issues at schools ill-equipped to help them.

What’s it like growing up and parenting in a digital world?

There’s a lot of fearmongering around children and their interactions with digital technology, but the truth is more nuanced.

A revolutionary new weapon in the battle against influenza

Clinical trials of an mRNA vaccine have begun and researchers expect broadly positive outcomes in the battle against the widespread illness.

(more…)

Bad medicine

Lessons from those who are succeeding at stamping out the toxic but persistent problem of substandard medicines

(more…)

When shopping online is deadly

Buying medicines on the internet saves time and money, but it could be deadly. Indonesia is working to regulate online pharmacies and improve public safety.

(more…)

How the pandemic set back drug safety

The best form of inspection is an unannounced one, but the pandemic changed the game for regulators. They’ll need to work together to protect consumers.

(more…)

Poor-quality medicines are everyone’s problem

COVID-19 has shown that regulatory processes can fail anywhere, allowing poor-quality medicines through. A new detection test could help shield consumers.

(more…)

A spoonful of sugar can stop the (fake) medicine going down

The key ingredient in detecting a counterfeit medicine could be in your kitchen.

(more…)

When the choice is between poor-quality medicine and no medicine at all

Poverty drives the market in inferior medicines just as it drives other examples of inequality. A socially integrated approach is needed to fight the problem.

(more…)

Who owns IP

Global perspectives on the state of intellectual property

(more…)

China’s Big Pharma bet could change the IP game

China’s muscling into the pharmaceutical industry, helping Big Pharma bite back against generics. But its global ambitions might turn the industry upside down.

(more…)

Less talk, more action needed to reform IP for all

IP laws are supposed to work to aid pharmaceutical innovation in rich nations. Can a new system support treating illnesses rife in developing economies, too?

(more…)

The untapped potential of effective non-drug treatments

Compiled by the Royal Australian College of General Practitioners, HANDI is the world’s first compendium of drug-free medical treatment.

(more…)

About Us

More

Stay up to date

Enjoy these stories?

Are the Olympic Games still relevant?

How schools are failing neurodivergent students

What’s it like growing up and parenting in a digital world?

A revolutionary new weapon in the battle against influenza

Bad medicine

When shopping online is deadly

How the pandemic set back drug safety

Poor-quality medicines are everyone’s problem

A spoonful of sugar can stop the (fake) medicine going down

When the choice is between poor-quality medicine and no medicine at all

Who owns IP

China’s Big Pharma bet could change the IP game

Less talk, more action needed to reform IP for all

The untapped potential of effective non-drug treatments

Enjoy these stories?

About

Our Policies

For journalists & newsrooms

For researchers

For non-media organisations